http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11427833-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5736c85c1929ce4e9775e836a65d6c05
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-8283
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01H6-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01H6-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01H6-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01H6-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-09
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01H6-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01H6-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01H6-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01H6-82
filingDate 2017-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2022-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00d8d2d9f93c8f51ab172695ea136459
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78fd867d05f4109edfa4c2a9609278a7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13e83a6b6b967d1cf3c7228325c4be8a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b9b1c23323d9db12fa266b613070cc1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ee2ce486fe94e6f787ad77e47407266
publicationDate 2022-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-11427833-B2
titleOfInvention Peptide effective in control of geminivirus disease and use thereof
abstract Disclosed are a decoy peptide which is a partial peptide of ASYMMETRIC LEAVES1 (AS1), the decoy peptide being capable of interacting with βC1 encoded by a betasatellite of a virus belonging to the family Geminiviridae, a nucleic acid encoding the decoy peptide, an expression vector comprising the nucleic acid, a geminivirus disease control agent comprising the decoy peptide or the nucleic acid, a method for controlling a geminivirus disease using the geminivirus disease control agent, a transgenic plant into which the nucleic acid is introduced, and a method for reducing a disease symptom caused by a virus that comprises βC1 and belongs to the family Geminiviridae, using the nucleic acid. Also disclosed is a method for evaluating the degree of reduction in a disease symptom caused by a virus that comprises βC1 and belongs to the family Geminiviridae.
priorityDate 2016-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006211854-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005291742-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015112052-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006194959-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006252920-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1033405-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006281909-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7361749-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009203891-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015057441-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006199952-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006270842-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006194958-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006229443-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009182122-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9000140-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006206954-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006217541-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006037098-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006229442-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014288287-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012077968-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011028704-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006084796-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007181453-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8853493-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006211853-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017037426-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006217545-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014058075-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006212963-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006235217-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006217543-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013102767-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006235218-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006211852-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006217544-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016076046-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1586645-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006212962-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006217540-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007179287-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006217542-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006031960-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006217539-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419517524
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6106
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17198
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7291
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419510698
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490523

Total number of triples: 82.